IRONWOOD PHARMACEUTICALS, INC. Operating Cash Flow
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Operating Cash Flow of $63.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $58.28M.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $5.12M, a 74.34% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $74.58M, a 390.17% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $47.58M, a 381.37% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2025 was $127.04M, a 22.69% increase from fiscal 2024.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2024 was $103.55M, a 43.55% decline from fiscal 2023.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2023 was $183.43M, a 33.00% decline from fiscal 2022.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2022 was $273.76M, a 4.53% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $58.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $63.40M 10-Q · filed 2026-08-06 | $137.97M derived: sum of 3 quarters · filed 2026-08-06 | $185.56M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $5.12M 10-Q · filed 2026-05-07 | $79.70M derived: sum of 2 quarters · filed 2026-05-07 | $127.28M derived: sum of 3 quarters · filed 2026-05-07 | $112.21M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $74.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $122.16M derived: sum of 2 quarters · filed 2026-02-26 | $107.09M derived: sum of 3 quarters · filed 2026-08-06 | $127.04M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $47.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $32.52M derived: sum of 2 quarters · filed 2026-08-06 | $52.47M 10-Q · filed 2025-11-10 | $67.68M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | -$15.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.89M 10-Q · filed 2026-08-06 | $20.10M derived: sum of 3 quarters · filed 2026-08-06 | $29.98M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $19.95M 10-Q · filed 2026-05-07 | $35.17M derived: sum of 2 quarters · filed 2026-05-07 | $45.05M derived: sum of 3 quarters · filed 2026-05-07 | $78.52M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $15.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $25.10M derived: sum of 2 quarters · filed 2026-02-26 | $58.56M derived: sum of 3 quarters · filed 2026-02-26 | $103.55M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $9.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $43.35M derived: sum of 2 quarters · filed 2025-11-10 | $88.33M 10-Q · filed 2025-11-10 | $124.17M derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | $33.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $78.45M 10-Q · filed 2025-08-11 | $114.28M derived: sum of 3 quarters · filed 2025-08-11 | $146.74M derived: sum of 4 quarters · filed 2025-08-11 | |||
| 2024-03-31 | $44.98M 10-Q · filed 2025-05-12 | $80.82M derived: sum of 2 quarters · filed 2025-05-12 | $113.28M derived: sum of 3 quarters · filed 2025-05-12 | $148.24M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | $35.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $68.29M derived: sum of 2 quarters · filed 2025-03-31 | $103.26M derived: sum of 3 quarters · filed 2025-03-31 | $183.43M 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $32.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $67.42M derived: sum of 2 quarters · filed 2024-11-07 | $147.59M 10-Q · filed 2024-11-07 | $226.78M derived: sum of 4 quarters · filed 2025-03-31 | |||
| 2023-06-30 | $34.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $115.13M 10-Q · filed 2024-08-08 | $194.32M derived: sum of 3 quarters · filed 2025-03-31 | $263.41M derived: sum of 4 quarters · filed 2025-03-31 | |||
| 2023-03-31 | $80.17M 10-Q · filed 2024-05-09 | $159.35M derived: sum of 2 quarters · filed 2025-03-31 | $228.44M derived: sum of 3 quarters · filed 2025-03-31 | $289.81M derived: sum of 4 quarters · filed 2025-03-31 | |||
| 2022-12-31 | $79.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $148.27M derived: sum of 2 quarters · filed 2025-03-31 | $209.64M derived: sum of 3 quarters · filed 2025-03-31 | $273.76M 10-K · filed 2025-03-31 | |||
| 2022-09-30 | $69.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $130.46M derived: sum of 2 quarters · filed 2023-11-09 | $194.58M 10-Q · filed 2023-11-09 | $259.15M derived: sum of 4 quarters · filed 2024-02-16 | |||
| 2022-06-30 | $61.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $125.49M 10-Q · filed 2023-08-09 | $190.06M derived: sum of 3 quarters · filed 2024-02-16 | $265.12M derived: sum of 4 quarters · filed 2024-02-16 | |||
| 2022-03-31 | $64.12M 10-Q · filed 2023-05-04 | $128.69M derived: sum of 2 quarters · filed 2024-02-16 | $203.76M derived: sum of 3 quarters · filed 2024-02-16 | $252.32M derived: sum of 4 quarters · filed 2024-02-16 | |||
| 2021-12-31 | $64.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $139.63M derived: sum of 2 quarters · filed 2024-02-16 | $188.20M derived: sum of 3 quarters · filed 2024-02-16 | $261.89M 10-K · filed 2024-02-16 | |||
| 2021-09-30 | $75.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $123.63M derived: sum of 2 quarters · filed 2022-11-03 | $197.33M 10-Q · filed 2022-11-03 | $248.84M derived: sum of 4 quarters · filed 2023-02-16 | |||
| 2021-06-30 | $48.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $122.26M 10-Q · filed 2022-08-04 | $173.78M derived: sum of 3 quarters · filed 2023-02-16 | $227.41M derived: sum of 4 quarters · filed 2023-02-16 | |||
| 2021-03-31 | $73.69M 10-Q · filed 2022-05-05 | $125.21M derived: sum of 2 quarters · filed 2023-02-16 | $178.84M derived: sum of 3 quarters · filed 2023-02-16 | $198.93M derived: sum of 4 quarters · filed 2023-02-16 | |||
| 2020-12-31 | $51.51M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $105.14M derived: sum of 2 quarters · filed 2023-02-16 | $125.23M derived: sum of 3 quarters · filed 2023-02-16 | $168.84M 10-K · filed 2023-02-16 | |||
| 2020-09-30 | $53.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $73.72M derived: sum of 2 quarters · filed 2021-11-04 | $117.32M 10-Q · filed 2021-11-04 | $144.90M derived: sum of 4 quarters · filed 2022-02-18 | |||
| 2020-06-30 | $20.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $63.69M 10-Q · filed 2021-08-05 | $91.27M derived: sum of 3 quarters · filed 2022-02-18 | $126.04M derived: sum of 4 quarters · filed 2022-02-18 | |||
| 2020-03-31 | $43.60M 10-Q · filed 2021-05-06 | $71.18M derived: sum of 2 quarters · filed 2022-02-18 | $105.95M derived: sum of 3 quarters · filed 2022-02-18 | $96.71M derived: sum of 4 quarters · filed 2022-02-18 | |||
| 2019-12-31 | $27.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $62.35M derived: sum of 2 quarters · filed 2022-02-18 | $53.11M derived: sum of 3 quarters · filed 2022-02-18 | $10.72M 10-K · filed 2022-02-18 | |||
| 2019-09-30 | $34.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $25.53M derived: sum of 2 quarters · filed 2020-11-05 | -$16.86M 10-Q · filed 2020-11-05 | -$7.58M derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2019-06-30 | -$9.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$51.62M 10-Q · filed 2020-08-06 | -$42.35M derived: sum of 3 quarters · filed 2021-02-17 | -$68.93M derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2019-03-31 | -$42.38M 10-Q · filed 2020-05-06 | -$33.11M derived: sum of 2 quarters · filed 2021-02-17 | -$59.69M derived: sum of 3 quarters · filed 2021-02-17 | -$82.38M derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2018-12-31 | $9.27M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | -$17.30M derived: sum of 2 quarters · filed 2021-02-17 | -$40.00M derived: sum of 3 quarters · filed 2021-02-17 | -$70.88M 10-K · filed 2021-02-17 | |||
| 2018-09-30 | -$26.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$49.27M derived: sum of 2 quarters · filed 2019-10-31 | -$80.16M 10-Q · filed 2019-10-31 | -$89.37M derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2018-06-30 | -$22.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | -$53.58M 10-Q · filed 2019-07-30 | -$62.79M derived: sum of 3 quarters · filed 2020-02-13 | -$94.03M derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2018-03-31 | -$30.89M 10-Q · filed 2019-05-02 | -$40.10M derived: sum of 2 quarters · filed 2020-02-13 | -$71.34M derived: sum of 3 quarters · filed 2020-02-13 | -$103.79M derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2017-12-31 | -$9.21M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$40.46M derived: sum of 2 quarters · filed 2020-02-13 | -$72.91M derived: sum of 3 quarters · filed 2020-02-13 | -$100.75M 10-K · filed 2020-02-13 | -$99.56M 10-K · filed 2018-02-22 | ||
| 2017-09-30 | -$31.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$63.69M derived: sum of 2 quarters · filed 2018-11-06 | -$91.54M 10-Q · filed 2018-11-06 | -$90.35M 10-Q · filed 2017-11-02 | -$110.73M derived: sum of 4 quarters · filed 2019-02-25 | ||
| 2017-06-30 | -$32.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$60.30M 10-Q · filed 2018-08-06 | -$59.11M 10-Q · filed 2017-08-03 | -$79.48M derived: sum of 3 quarters · filed 2019-02-25 | -$80.13M derived: sum of 4 quarters · filed 2019-02-25 | ||
| 2017-03-31 | -$27.85M 10-Q · filed 2018-05-04 | -$47.03M derived: sum of 2 quarters · filed 2019-02-25 | -$47.68M derived: sum of 3 quarters · filed 2019-02-25 | ||||
| 2016-12-31 | -$19.19M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | -$19.83M derived: sum of 2 quarters · filed 2019-02-25 | -$25.93M 10-K · filed 2019-02-25 | -$25.43M 10-K · filed 2017-02-22 | |||
| 2016-09-30 | -$645.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$6.75M 10-Q · filed 2017-11-02 | |||||
| 2016-06-30 | -$6.10M 10-Q · filed 2017-08-03 | ||||||
| 2015-12-31 | -$106.93M 10-K · filed 2018-02-22 | ||||||
| 2015-03-31 | -$35.78M 10-Q · filed 2015-05-06 | -$58.57M derived: sum of 2 quarters · filed 2017-02-22 | -$97.25M derived: sum of 3 quarters · filed 2017-02-22 | -$133.46M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2014-12-31 | -$22.78M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | -$61.46M derived: sum of 2 quarters · filed 2017-02-22 | -$97.67M derived: sum of 3 quarters · filed 2017-02-22 | -$155.57M 10-K · filed 2017-02-22 | |||
| 2014-09-30 | -$38.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | -$74.89M derived: sum of 2 quarters · filed 2014-11-05 | -$132.78M 10-Q · filed 2014-11-05 | -$174.86M derived: sum of 4 quarters · filed 2015-05-06 | |||
| 2014-06-30 | -$36.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$94.10M 10-Q · filed 2014-08-05 | -$136.18M derived: sum of 3 quarters · filed 2015-05-06 | -$194.14M derived: sum of 4 quarters · filed 2015-05-06 | |||
| 2014-03-31 | -$57.89M 10-Q · filed 2015-05-06 | -$99.97M derived: sum of 2 quarters · filed 2015-05-06 | -$157.93M derived: sum of 3 quarters · filed 2015-05-06 | -$238.07M derived: sum of 4 quarters · filed 2015-05-06 | |||
| 2013-12-31 | -$42.08M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | -$100.03M derived: sum of 2 quarters · filed 2015-02-18 | -$180.17M derived: sum of 3 quarters · filed 2015-02-18 | -$273.36M 10-K · filed 2015-02-18 | |||
| 2013-09-30 | -$57.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | -$138.09M derived: sum of 2 quarters · filed 2014-11-05 | -$231.28M 10-Q · filed 2014-11-05 | -$253.74M derived: sum of 4 quarters · filed 2015-02-18 | |||
| 2013-06-30 | -$80.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$173.32M 10-Q · filed 2014-08-05 | -$195.78M derived: sum of 3 quarters · filed 2015-02-18 | -$156.79M derived: sum of 4 quarters · filed 2015-02-18 | |||
| 2013-03-31 | -$93.18M 10-Q · filed 2014-04-29 | -$115.64M derived: sum of 2 quarters · filed 2015-02-18 | -$76.65M derived: sum of 3 quarters · filed 2015-02-18 | -$119.75M derived: sum of 4 quarters · filed 2015-02-18 | |||
| 2012-12-31 | -$22.46M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $16.54M derived: sum of 2 quarters · filed 2015-02-18 | -$26.57M derived: sum of 3 quarters · filed 2015-02-18 | -$69.63M 10-K · filed 2015-02-18 | |||
| 2012-09-30 | $38.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | -$4.11M derived: sum of 2 quarters · filed 2013-10-28 | -$47.17M 10-Q · filed 2013-10-28 | -$54.88M derived: sum of 4 quarters · filed 2014-02-07 | |||
| 2012-06-30 | -$43.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$86.17M 10-Q · filed 2013-08-08 | -$93.87M derived: sum of 3 quarters · filed 2014-02-07 | -$119.28M derived: sum of 4 quarters · filed 2014-02-07 | |||
| 2012-03-31 | -$43.06M 10-Q · filed 2013-04-23 | -$50.76M derived: sum of 2 quarters · filed 2014-02-07 | -$76.18M derived: sum of 3 quarters · filed 2014-02-07 | ||||
| 2011-12-31 | -$7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-07 | -$33.12M derived: sum of 2 quarters · filed 2014-02-07 | -$75.24M 10-K · filed 2014-02-07 | ||||
| 2011-09-30 | -$25.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | -$67.54M 10-Q · filed 2011-11-09 | |||||
| 2011-06-30 | -$42.12M 10-Q · filed 2011-08-12 | ||||||
| 2010-12-31 | -$646.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | -$23.42M derived: sum of 2 quarters · filed 2013-02-21 | -$67.90M 10-K · filed 2013-02-21 | ||||
| 2010-09-30 | -$22.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | -$67.25M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | -$44.48M 10-Q · filed 2011-08-12 | ||||||
| 2009-12-31 | -$3.44M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |